President Trump’s top health official has appointed a new drug pricing chief after the prior official in that position died last month.

John O’Brien, a current official in the Department of Health and Human Services, will be senior adviser to the health secretary who is responsible for drug pricing reform. He replaces Dan Best, who died Nov. 1.